Detail
| LncRNA Name | ANRIL |
| Synonyms | CDKN2B-AS1, ANRIL, CDKN2B-AS, CDKN2BAS, NCRNA00089, PCAT12, p15AS |
| Region | GRCh38_9:21994778-22121097 Sequence |
| Ensembl | ENSG00000240498 |
| RefSeq | NR_003529 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | osteosarcoma |
| ICD-0-3 | M9180/3 |
| Methods | qPCR etc. |
| Sample | cell line U2OS |
| Expression Pattern | up-regulated |
| Function Description | The expression of lncRNA ANRIL is increased in hepatocellular carcinoma, and demonstrated that it serves a role in tumor proliferation and metastasis. The results of these studies therefore suggest that dysregulation of ANRIL may be a contributing factor in human cancer progression. |
| Pubmed ID | 29201225 |
| Year | 2017 |
| Title | Long non-coding RNA ANRIL promotes the proliferation, migration and invasion of human osteosarcoma cells |
| External Links |
| Links for ANRIL | GenBank HGNC lncrnadb Noncode |
| Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.